Effects of immunomodulation in classic infantile Pompe patients with high antibody titers

Author(s):
Poelman, E.; Hoogeveen-Westerveld, M.; Hout, J.M.P. van den; Bredius, R.G.M.; Lankester, A.C.; Driessen, G.J.A.; Kamphuis, S.S.M.; Pijnappel, W.W.M.; Ploeg, A.T. van der
Published
2019
Publication type
Article / Letter to editor
Pompe diseaseERTAntibodiesImmunomodulationBortezomibCross-reactive immunologic material (CRIM)
Date issued
2019-03-22
Language
English
Is part of
Orphanet Journal of Rare Diseases
hdl
1887/120449
doi
10.1186/s13023-019-1039-z